This data suggests that the in vitro regulation of plasminogen activation by ALDH1A3 is strongly reflected between ALDH1A3 and tPA in breast cancer patient tumours but not apparent between ALDH1A3 and uPA, or ALDH1A3 and PAI‐2. Here, SERPINB2 is linked to breast carcinoma.